Found 63 matching trials
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy
PHASE3This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Location
Henan Cancer Hospital
Trial on Delay Phenomenon Utility in Preventing Anastomotic Leakage After an Esophagectomy
NAThis is a randomized clinical trial to clarify if the delay phenomenon coul...
Location
Leandre Farran Teixidor
Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma
NAThis is a randomized noninferiority multicenter trial. Patients will be str...
Status
Active Not Recruiting
Location
National Cancer Center
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
PHASE3The purpose of this study is to evaluate the safety, feasibility and outcom...
Location
N.N. Blokhin National Medical Research Center of Oncology
Open Versus Laparoscopically-assisted Esophagectomy for Cancer
NATo compare laparoscopically-assisted gastric mobilization versus open gastr...
Location
Hopital Du Haut Leveque
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
PHASE2This study is conducted to evaluate efficacy and safety of neoadjuvant chem...
Use of Bemiparine as a Prophylactic Antithrombotic Agent, in Patients Undergoing Microsurgery for Head and Neck Reconstruction
N/AA comparative study to reveal if the use of Bemiparine (Hibor) versus Enoxa...
Location
Ramon y Cajal Hospital
Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients
N/AThe same initial and long-term anticoagulation is suggested for unsuspected...
Location
D.C. Veterans Affairs Medical Center
Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2China with high incidence of esophageal cancer, the number of new cases and...
Status
Active Not Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University